Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Ganesha (psychedelic)

From Wikipedia, the free encyclopedia
Psychedelic drug
For other uses, seeGanesha (disambiguation).
Pharmaceutical compound
Ganesha
Clinical data
Other namesGANESHA; G; G-0; 3C-G; 3,4-Dimethyl-2,5-dimethoxyamphetamine; 2,5-Dimethoxy-3,4-dimethylamphetamine; 3-Methyl-DOM; 3-Me-DOM; DOG; DOG-0
Routes of
administration
Oral[1]
Drug classSerotonergic psychedelic;Hallucinogen
ATC code
  • None
Pharmacokinetic data
Onset of actionSlow over 3 hours or rapid[1]
Duration of action18–24 hours[1]
Identifiers
  • 1-(2,5-dimethoxy-3,4-dimethylphenyl)propan-2-amine
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC13H21NO2
Molar mass223.316 g·mol−1
3D model (JSmol)
  • COc1c(C)c(C)c(cc1CC(C)N)OC
  • InChI=1S/C13H21NO2/c1-8(14)6-11-7-12(15-4)9(2)10(3)13(11)16-5/h7-8H,6,14H2,1-5H3 checkY
  • Key:RBZXVDSILZXPDM-UHFFFAOYSA-N checkY
  (verify)

Ganesha (G orG-0), also known as3,4-dimethyl-2,5-dimethoxyamphetamine or as3-methyl-DOM, is apsychedelic drug of thephenethylamine,amphetamine, andDOx families.[1] It is the 3-methylderivative ofDOM and the amphetamine (α-methyl) derivative of2C-G.[1] The drug is takenorally.[1]

Use and effects

[edit]

In his bookPiHKAL (Phenethylamines I Have Known and Loved),Alexander Shulgin lists Ganesha's dose range as 24 to 32 mgorally and itsduration as 18 to 24 hours.[1] The drug'sonset was variably described as slow over the course of 3 hours or as rapid.[1] The effects of Ganesha have been reported to include strongclosed-eye visuals, an increased appreciation ofmusic, and powerfulrelaxation andtranquility, among others.[1] Shulgin named Ganesha after theHindu deity,Ganesha.[1] It is one of his "ten classic ladies", a series ofmethylatedDOMderivatives.[1][2]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Chemistry

[edit]

Synthesis

[edit]

Thechemical synthesis of Ganesha has been described.[1]

Homologues

[edit]
See also:2C-G § Homologues, andDOx § Related compounds

Homologues of Ganesha (G-0) includeG-3,G-4,G-5, andG-N, among others.[1]

CompoundDetailsStructure
G-3CAS #: 207740-36-1

Dose: 12–18 mg
Duration: 8–12 hours
Effects: Closed-eye imagery, no visuals, fantasy, no body load, neurological sensitivity, others
2C analogue:2C-G-3

G-4CAS #: Unknown

Partially synthesized but not tested.
2C analogue:2C-G-4

G-5CAS #: 133787-68-5

Dose: 14–20 mg
Duration: 16–30 hours
Effects: No visuals or other sensory effects, excellent mental activity, mental integration, lacking something important, little or no body load
2C analogue:2C-G-5

G-NCAS #: 477904-62-4

Synthesized and tested at 2 mg but not up to active levels
2C analogue:2C-G-N

G-O[3]CAS #: 774538-38-4

Described and/or synthesized but not tested
2C analogue: None

History

[edit]

Ganesha was first described in the literature byAlexander Shulgin in his bookPiHKAL (Phenethylamines I Have Known and Loved) in 1991.[1]

Society and culture

[edit]

Legal status

[edit]

Canada

[edit]

Ganesha is acontrolled substance inCanada under phenethylamine blanket-ban language.[4]

United Kingdom

[edit]

This substance is a Class A drug in theDrugs controlled by the UK Misuse of Drugs Act.[5]

United States

[edit]

Ganesha is not an explicitlycontrolled substance in theUnited States.[6] However, it could be considered acontrolled substance under theFederal Analogue Act if intended for human consumption. In addition, the drug may considered a controlled substance as apositional isomer ofDOET.[6][7]

See also

[edit]

References

[edit]
  1. ^abcdefghijklmnShulgin, Alexander;Shulgin, Ann (September 1991).PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press.ISBN 0-9630096-0-5.OCLC 25627628.http://www.erowid.org/library/books_online/pihkal/pihkal085.shtml
  2. ^Ger A, Ger D (April 2011)."Triple Goddess of the Night".British Neuroscience Association Bulletin.63:28–30.
  3. ^Hellberg MR, Namil A. Benzopyran analogs and their use for the treatment of glaucoma. Patent US 7396856
  4. ^"Controlled Drugs and Substances Act".Department of Justice Canada. Retrieved19 January 2026.
  5. ^"UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived fromthe original on 22 October 2017. Retrieved12 March 2014.
  6. ^abOrange Book: List of Controlled Substances and Regulated Chemicals (January 2026)(PDF),United States: U.S.Department of Justice:Drug Enforcement Administration (DEA): Diversion Control Division, January 2026
  7. ^Drug Enforcement Administration (3 December 2007)."Definition of "Positional Isomer" as It Pertains to the Control of Schedule I Controlled Substances".Federal Register.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
Others
Natural sources
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=Ganesha_(psychedelic)&oldid=1334208451"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp